Clear 618 Results Filter Filter Results Type: Press Release Abiomed Announces Q2 FY 2021 Revenue of $210 Million Up 27% Over Q1 FY 2021 and Up 2% Over Q2 FY 2020 With 292% Operating Margin Type: Press Release First Patients Treated with the World’s Smallest Heart Pump the 9Fr Impella ECP Type: Press Release FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology Type: Press Release Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP Type: Press Release Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival Particularly in Women Type: Press Release Abiomed to Host a Virtual Meeting to Discuss New Clinical Data Presented at TCT Connect Type: Press Release Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes Type: Press Release Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction Type: Press Release Abiomed Second Quarter Fiscal 2021 Earnings and Conference Call Notification Type: Press Release TCT Connect to Highlight How Impella Enables Improved Outcomes for High-Risk PCI Cardiogenic Shock and Right Heart Failure Patients … 37 38 39 40 …
